Pilot study to evaluate the safety and therapeutic efficacy of topical oxifulvic acid in atopic volunteers

Drug Development Research

Volumn 57, Issue 1, 2002, Pages 40-43

  Snyman, J R ^a   Dekker, J ^b   Malfeld, S C K ^a   Van Rensburg, C E J ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Enerkom (Pty) Ltd   (South Africa)

Author keywords

Atopy; Oxifulvic acid; Safety

Indexed keywords

ANTIINFLAMMATORY AGENT; HOUSE DUST ALLERGEN; HYDROCORTISONE; OXIFULVIC ACID; PLACEBO; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPY; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INTRACUTANEOUS TEST; KIDNEY FUNCTION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0036758541     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10116     Document Type: Article

References (9)

1. Bergh JJ, Cronje IJ, Dekker J, Dekker TG, Gerritsma LM, Mienie LJ. 1997, Non-catalytic oxidation of water-slurried coal with oxygen: Identification of fulfic acid and acute toxicity. Fuel 76:147-154.
2. Lopez-Fernandez MF, Blanco-Lopez MJ, Castineria MP, Batlle J. 1992. Further evidence for recessive inheritance of von Willebrands disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 40:20-27.
3. MaCarthe P, Clapp CE, Malcolm RL, Bloom PR. 1985. Humic substances in soil and crop sciences; selected readings. Proceedings Symposium International Humic Substances Society of America, Chicago, IL, 2 December.
4. Salz H. 1974. Salhumin-Gel; ein lokaltheropeutikum mit hyperonisierender entzindungshemmender und analgetischer wirkung. Med Monatsschr 28:548-530.
5. Snyman JR, Sommers De K, Van Wyk M, Geregorowski MD. 1995. The influence of betahistine on the dynamics of the cutaneous hypersensitivity reactions in patients with grass pollen allergy. Immunopharmacology 30:71-78.
6. Solovyeva VP, Lotosh TD. 1984. Biologically active peat substances as body resistance stimulators. Proc 7th Int Peat Congress. 4: 428-434.
7. van Rensburg CEJ, Van Straten A, Dekker J. 2000. An in vitro investigation of the antimicrobial activity of oxifulvic acid. J Antimicrob Chemother 46:853.
8. van Rensburg CEJ, Malfeld SCK, Dekker J. 2001. Topical application of oxifulvic acid suppresses the cutaneous immune response in mice. Drug Dev Res 53:29-32.
9. Wang C, Wang Z, Peng A, Hou J, Xin W. 1996. Interaction between fulvic acids of different origins and active oxygen radicals. Sci China C Life Sci 39(B):267-275.